Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1CNS 1

Conditions

Melanoma 74Hodgkin Disease 56Lymphoma 22Sarcoma 13Neoplasm Metastasis 11Leiomyosarcoma 8Uveal Melanoma 7Neoplasms 7Skin Neoplasms 6Neuroblastoma 4Sarcoma, Synovial 3Recurrence 3Solitary Fibrous Tumors 2Sarcoma, Alveolar Soft Part 2Hematologic Diseases 2HIV Infections 2Thyroid Neoplasms 1Solid Tumor 1Small Cell Lung Carcinoma 1Skin Diseases 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Parathyroid Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Melanoma, Cutaneous Malignant 1Melanoma Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7Temozolomide 6Radiotherapy 5Surgical Procedures, Operative 3Imatinib Mesylate 3Biopsy 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3sargramostim 2Tamoxifen 2Donepezil 2Congresses as Topic 2Cisplatin 2Carboplatin 2temsirolimus 1lonafarnib 1gallium Ga 68 dotatate 1fluorodopa F 18 1entinostat 1carboxyamido-triazole 1aldesleukin 1Vinblastine 1Verteporfin 1Topotecan 1Thalidomide 1Surveys and Questionnaires 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma, Subependymal × Dacarbazine × Clear all
NCT00498979 2020-07-24

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Case Comprehensive Cancer Center

Phase 1 Completed
22 enrolled
CNSDermatologicSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Melanoma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡